Literature DB >> 18480316

Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD.

Gérard M London1, Sylvain J Marchais, Alain P Guérin, Pierre Boutouyrie, Fabien Métivier, Marie-Christine de Vernejoul.   

Abstract

An inverse relationship between arterial calcifications and bone activity has been documented in patients with ESRD. Calcium overload is associated with arterial calcification, which is associated with arterial stiffening. Whether bone activity interacts with calcium load, aortic stiffness, or arterial calcification is unknown. This study assessed the impact of bone activity on the relationships between the dosage of calcium-containing phosphate binders and aortic stiffness (measured by pulse wave velocity) or abdominal aorta calcification score. Aortic stiffness and calcification were both positively associated with calcium load and negatively associated with bone activity. A significant interaction was found between dosage of calcium-containing phosphate binders and bone activity such that calcium load had a significantly greater influence on aortic calcifications and stiffening in the presence of adynamic bone disease. Independent of any other factor, including dosage of calcium-containing phosphate binders, adynamic bone was associated with greater aortic stiffening, suggesting cross-talk between the bone and arterial walls.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480316      PMCID: PMC2518431          DOI: 10.1681/ASN.2007050622

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  46 in total

1.  Effects of cigarette-smoking on bone mass as assessed by dual-energy X-ray absorptiometry and ultrasound.

Authors:  P Gerdhem; K J Obrant
Journal:  Osteoporos Int       Date:  2002-12       Impact factor: 4.507

2.  The renal osteodystrophy pattern in Brazil and Uruguay: an overview.

Authors:  Sonia M Holanda Almeida Araújo; Pablo Ambrosoni; Rosélia R Santos Lobão; Hena Caorsi; Rosa M A Moysés; Fellype Carvalho Barreto; Inés Olaizola; Elisa A S Cruz; Alicia Petraglia; Luciene M Dos Reis; Maria Eugênia Duarte; Vanda Jorgetti; Aluizio B Carvalho
Journal:  Kidney Int Suppl       Date:  2003-06       Impact factor: 10.545

3.  Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study.

Authors:  D P Kiel; L I Kauppila; L A Cupples; M T Hannan; C J O'Donnell; P W Wilson
Journal:  Calcif Tissue Int       Date:  2001-05       Impact factor: 4.333

4.  Aluminum chloride pretreatment of elastin inhibits elastolysis by matrix metalloproteinases and leads to inhibition of elastin-oriented calcification.

Authors:  M Bailey; H Xiao; M Ogle; N Vyavahare
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

5.  Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients.

Authors:  Angela Yee Moon Wang; Jean Woo; Mei Wang; Mandy Man Mei Sea; Ricky Ip; Philip Kam Tao Li; Siu Fai Lui; John Elsby Sanderson
Journal:  J Am Soc Nephrol       Date:  2001-09       Impact factor: 10.121

6.  Leptin enhances the calcification of vascular cells: artery wall as a target of leptin.

Authors:  F Parhami; Y Tintut; A Ballard; A M Fogelman; L L Demer
Journal:  Circ Res       Date:  2001-05-11       Impact factor: 17.367

7.  C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Michelle J Kupka; Warren J Manning; Melvin E Clouse; Ralph B D'Agostino; Peter W F Wilson; Christopher J O'Donnell
Journal:  Circulation       Date:  2002-09-03       Impact factor: 29.690

8.  Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

Authors:  Gérard M London; Alain P Guérin; Sylvain J Marchais; Fabien Métivier; Bruno Pannier; Hasan Adda
Journal:  Nephrol Dial Transplant       Date:  2003-09       Impact factor: 5.992

9.  Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.

Authors:  Glenn M Chertow; Steven K Burke; Paolo Raggi
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

10.  Serum leptin in dialysis renal osteodystrophy.

Authors:  Giorgio Coen; Paola Ballanti; Maria Stephanie Fischer; Alessandro Balducci; Santo Calabria; Luisa Colamarco; Giacomo Di Zazzo; Francesca Lifrieri; Micaela Manni; Daniela Sardella; Italo Nofroni; Ermanno Bonucci
Journal:  Am J Kidney Dis       Date:  2003-11       Impact factor: 8.860

View more
  78 in total

Review 1.  The bone-vascular axis in chronic kidney disease.

Authors:  Linda Demer; Yin Tintut
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-07       Impact factor: 2.894

2.  Not only for the risk of bone fracture.

Authors:  Masafumi Fukagawa
Journal:  J Bone Miner Metab       Date:  2015-05-12       Impact factor: 2.626

Review 3.  Calcium and the saga of the binders: accumulating controversy, or building consensus?

Authors:  David J A Goldsmith; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2008-10-04       Impact factor: 2.370

Review 4.  Renale osteodystrophie.

Authors:  Daniel Cejka
Journal:  Wien Med Wochenschr       Date:  2013-05-09

Review 5.  Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease.

Authors:  János Nemcsik; István Kiss; András Tislér
Journal:  World J Nephrol       Date:  2012-02-06

6.  Serum calcification propensity predicts all-cause mortality in predialysis CKD.

Authors:  Edward R Smith; Martin L Ford; Laurie A Tomlinson; Emma Bodenham; Lawrence P McMahon; Stefan Farese; Chakravarthi Rajkumar; Stephen G Holt; Andreas Pasch
Journal:  J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 10.121

7.  Increased risk of cardiovascular events in end-stage renal disease patients with osteoporosis: a nationwide population-based cohort study.

Authors:  T-M Yu; C-L Lin; K-H Shu; Y-L Liu; C-H Chen; S-T Huang; C-H Kao
Journal:  Osteoporos Int       Date:  2014-12-10       Impact factor: 4.507

8.  Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients.

Authors:  Nathan A Hewitt; Alicia A O'Connor; Denise V O'Shaughnessy; Grahame J Elder
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-14       Impact factor: 8.237

Review 9.  Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension.

Authors:  Monica M Santisteban; Jasenka Zubcevic; David M Baekey; Mohan K Raizada
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

10.  The association between parathyroid hormone and mortality in dialysis patients is modified by wasting.

Authors:  Christiane Drechsler; Vera Krane; Diana C Grootendorst; Eberhard Ritz; Karl Winkler; Winfried März; Friedo Dekker; Christoph Wanner
Journal:  Nephrol Dial Transplant       Date:  2009-05-27       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.